Priming Intervention for Psoriasis
What You Need to Know Before You Apply
What is the purpose of this trial?
Biologic medications have revolutionized the treatment of inflammatory diseases such as moderate-to-severe psoriasis. Though very effective with an excellent safety profile, patients may be apprehensive about choosing a biologic medication for a variety of reasons. The purpose of this research study is to learn more about patient's perception of certain psoriasis treatment options.
Who Is on the Research Team?
Steven R Feldman
Principal Investigator
Wake Forest University
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with psoriasis or their caregivers. It's not open to those who have already tried and did not respond well to specific biologic drugs like ustekinumab, guselkumab, risankizumab, or tildrakizumab.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey Administration
Participants are randomized into three groups and administered surveys querying willingness to use a biologic medication
Follow-up
Participants are monitored for survey responses and willingness to use biologic medication
What Are the Treatments Tested in This Trial?
Interventions
- Group #2 (Intervention)
- Group #3 (Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor